Join Experts and Patients in NYC for a Day of Learning and Connecting Register Free Today
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Learn more about this revolutionary cancer treatment.
Understand the Basics
Find clinical trials that match your diagnosis, stage and treatment history.
Meet the CRI scientists committed to the development of immunotherapy.
First-of-its kind campaign to fund promising immunotherapy research in Israel, a global leader in cancer research
Fight Colorectal Cancer and the Cancer Research Institute announce the recipient of their jointly-funded $400k grant to support immunotherapy research in metastatic colorectal cancer.
CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system
The Focused Ultrasound Foundation (FUSF) and the Cancer Research Institute (CRI) are establishing a partnership with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy treatments.
The Cancer Research Institute 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to provide free educational programming designed for cancer patients and caregivers who are seeking to learn more about cancer immunotherapy and clinical trials.
*Immunotherapy results may vary from patient to patient.
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Biomarkers will be crucial to taking advantage of combination immunotherapy’s full potential
Nivolumab becomes second checkpoint immunotherapy approved for colorectal cancer